BIOMAT Database Logo BIOMAT Database Logo

[Risk factors in cancer of the endometrium]. 1987

J J Baldauf, and J Ritter, and A Ben Mansour, and J Andrianivo, and C Lecornu, and R Gandar

The authors evaluate the incidence of the main risk factors in endometrial cancer by comparing a continuous series of 101 patients with a matched reference series. Among these factors, obesity and multiparity are significantly more frequent in patients with endometrial cancer. All of these risk factors are related to a hyperestrogen level. Their knowledge may contribute to a policy of prevention of endometrial cancer, but does not permit its screening by limiting to women presenting these risk factors.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009378 Neoplasms, Multiple Primary Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites. Neoplasms, Synchronous,Neoplasms, Synchronous Multiple Primary,Multiple Primary Neoplasms,Multiple Primary Neoplasms, Synchronous,Synchronous Multiple Primary Neoplasms,Synchronous Neoplasms,Multiple Primary Neoplasm,Neoplasm, Multiple Primary,Neoplasm, Synchronous,Primary Neoplasm, Multiple,Primary Neoplasms, Multiple,Synchronous Neoplasm
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010298 Parity The number of offspring a female has borne. It is contrasted with GRAVIDITY, which refers to the number of pregnancies, regardless of outcome. Multiparity,Nulliparity,Primiparity,Parity Progression Ratio,Parity Progression Ratios,Ratio, Parity Progression,Ratios, Parity Progression
D011085 Polycystic Ovary Syndrome A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading. Stein-Leventhal Syndrome,Polycystic Ovarian Syndrome,Polycystic Ovary Syndrome 1,Sclerocystic Ovarian Degeneration,Sclerocystic Ovaries,Sclerocystic Ovary Syndrome,Ovarian Degeneration, Sclerocystic,Ovarian Syndrome, Polycystic,Ovary Syndrome, Polycystic,Ovary, Sclerocystic,Sclerocystic Ovary,Stein Leventhal Syndrome,Syndrome, Polycystic Ovary,Syndrome, Stein-Leventhal
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J J Baldauf, and J Ritter, and A Ben Mansour, and J Andrianivo, and C Lecornu, and R Gandar
High risk factors for cancer of the endometrium among Japanese women.
December 1987, Asia-Oceania journal of obstetrics and gynaecology,
J J Baldauf, and J Ritter, and A Ben Mansour, and J Andrianivo, and C Lecornu, and R Gandar
[Prognostic factors in cancer of the endometrium].
January 1988, Journal de gynecologie, obstetrique et biologie de la reproduction,
J J Baldauf, and J Ritter, and A Ben Mansour, and J Andrianivo, and C Lecornu, and R Gandar
Subsite (cervix/endometrium)-specific risk and protective factors in uterus cancer.
September 1996, Japanese journal of cancer research : Gann,
J J Baldauf, and J Ritter, and A Ben Mansour, and J Andrianivo, and C Lecornu, and R Gandar
A comparative study of risk factors for hyperplasia and cancer of the endometrium.
April 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP),
J J Baldauf, and J Ritter, and A Ben Mansour, and J Andrianivo, and C Lecornu, and R Gandar
Risk factors and current management in carcinoma of the endometrium.
June 1986, Surgery, gynecology & obstetrics,
J J Baldauf, and J Ritter, and A Ben Mansour, and J Andrianivo, and C Lecornu, and R Gandar
Risk-adapted therapy for cancer of the endometrium.
April 1993, European journal of obstetrics, gynecology, and reproductive biology,
J J Baldauf, and J Ritter, and A Ben Mansour, and J Andrianivo, and C Lecornu, and R Gandar
[Prognostic factors in cancer of the endometrium and therapeutic indications].
January 1984, Journal de gynecologie, obstetrique et biologie de la reproduction,
J J Baldauf, and J Ritter, and A Ben Mansour, and J Andrianivo, and C Lecornu, and R Gandar
Tubal sterilization and risk of cancer of the endometrium.
December 2000, Gynecologic oncology,
J J Baldauf, and J Ritter, and A Ben Mansour, and J Andrianivo, and C Lecornu, and R Gandar
[Importance of prognostic factors in the prognosis of cancer of the endometrium].
November 1992, Orvosi hetilap,
J J Baldauf, and J Ritter, and A Ben Mansour, and J Andrianivo, and C Lecornu, and R Gandar
[Prognostic factors of cancer of the endometrium and therapeutic implications].
June 1998, Contraception, fertilite, sexualite (1992),
Copied contents to your clipboard!